Press

Target Group Inc. Announces the Completion of Acquisition of Visava Inc.

8th August 2018

Effective August 2, 2018, Target Group Inc. (CBDY) completed the acquisition of all of the issued and outstanding common stock of Visava Inc. (“Visava”). Pursuant to the Agreement and Plan of Share Exchange dated June 27, 2018, the Company will issue 25,500,000 shares of its common stock to the Visava shareholders, plus warrants to purchase up to an additional 25,000,000 shares of the Company’s common stock at $0.10 per share for a period of two years from the date of closing. Visava, an Ontario, Canada corporation, will continue to operate as a wholly-owned subsidiary of the Company.

As  previously announced, Visava owns 100% of Canary Rx Inc., which is a Canadian corporation that is a late stage ACMPR applicant with Health Canada. Canary Rx Inc. holds a leasehold interest in a 44,000 sq. ft. parcel of property located in Ontario’s Norfolk County for the production of approximately 3,600,000 gr. of cannabis per year. On June 27, 2018, Canary Rx Inc. received a letter of readiness from Health Canada and will finish the buildout of the 44,000 sq. ft. facility within the next 90-120 days.

Canada’s recreational cannabis market is estimated by Deloitte at being worth up to $22.6 billion annually in total market turnover, more than beer, wine and spirit sales combined.

Canada is the largest developed nation with federally legalized cannabis industry. Health Canada’s data shows that, on average, current production is only meeting 26% of potential medical market demand. Canary is currently positioning itself as a premium cannabis lifestyle brand, with a focus on producing premium, unique & curated cannabis products.

View Press Release